Provided by Tiger Fintech (Singapore) Pte. Ltd.

Dr Reddy's Laboratories

12.92
+0.11000.86%
Pre-market: 12.950.0300+0.23%09:00 EST
Volume:1.78M
Turnover:22.92M
Market Cap:10.76B
PE:17.18
High:13.04
Open:12.92
Low:12.80
Close:12.81
Loading ...

Henlius and Dr. Reddy's Ink Licensing Deal for HLX15 (investigational daratumumab biosimilar) Expansion in Europe and the U.S.

PR Newswire
·
06 Feb

Asian Equities Traded in the US as American Depositary Receipts Fall in Friday Trading

MT Newswires Live
·
31 Jan

ReadyTech Holdings Ltd. (RDY) Receives a Buy from Wilsons

TIPRANKS
·
31 Jan

Asian Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading

MT Newswires Live
·
29 Jan

Asian Equities Traded in the US as ADRs Rise in Tuesday Trading

MT Newswires Live
·
28 Jan

Asian Equities Traded in the US as American Depositary Receipts Fall Sharply in Monday Trading

MT Newswires Live
·
27 Jan

Barclays Reaffirms Their Buy Rating on Dr Reddy’s Laboratories (RDY)

TIPRANKS
·
27 Jan

RDY Q3 Earnings Match Estimates, Generics Revenues Rise Y/Y, Stock Down

Zacks
·
25 Jan

Dr Reddy's Laboratories Ltd (RDY) Q3 2025 Earnings Call Highlights: Record Revenue Growth ...

GuruFocus.com
·
24 Jan

Dr Reddy's Laboratories Q3 Earnings: Double-Digit Growth Aided By Newly Acquired Nicotine Replacement Business

Benzinga
·
24 Jan

Dr Reddy's Laboratories Ltd reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
24 Jan

Dr. Reddy's Laboratories Fiscal Q3 Earnings, Revenue Rise

MT Newswires Live
·
24 Jan

Earnings Flash (RDY) Dr. Reddy's Laboratories Posts Fiscal Q3 EPS $0.20, vs. FactSet Est of $0.21

MT Newswires Live
·
24 Jan

Dr. Reddy’s Q3 & 9MFY25 Financial Results

Business Wire
·
24 Jan

Press Release: Dr. Reddy's Q3 & 9MFY25 Financial Results

Dow Jones
·
24 Jan

Stock Track | Dr Reddy's Laboratories Tumbles 5.77% on Disappointing Q3 Earnings, Underperformance in Asian Markets

Stock Track
·
23 Jan